natgillin/translations-raw huggingface dataset:
Recommended safety measures for removal and disposal of needles must be followed (e.g. a one handed capping technique) in order to reduce the risk of accidental needle injury and transmission of infectious diseases.
Upošteva naj priporočene varnostne ukrepe, ko igle odstranjuje in zavrže (npr. tehniko pokrivanja z eno roko), da boste zmanjšali tveganje za naključno poškodbo z iglo in prenos nalezljivih bolezni.
Recommended schedule for monitoring renal function considering the presence or absence of additional risk factors for renal impairment
Priporočeni časovni razpored za spremljanje ledvičnega delovanja, pri čemer je treba upoštevati prisotnost ali odsotnost dodatnih dejavnikov tveganja za ledvično okvaro
Recommended separation distance c
Priporočena razdalja c
Recommended separation distances between portable and mobile RF communications equipment and the administration system
Priporočene razdalje med aplikacijskim sistemom in mobilno komunikacijsko RF opremo
Recommended starting dose of ZYPADHERA
Priporočen začetni odmerek zdravila ZYPADHERA
Recommended storage is controlled refrigeration 2°C to 8°C in the closed original carton to protect from light.
Zdravilo je priporočljivo shranjevati v nadzorovanem hladilniku med 2 °C in 8 °C v zaprti originalni škatli za zagotovitev zaščite pred svetlobo.
recommended that EVOTAZ and
priporočljivo zdravilo EVOTAZ in
recommended that the lowest
darunavir/ritonavirjem, na začetku
recommended that the lowest
ki se že zdravijo z
recommended that the tacrolimus
takrolimusa priporočljivo
recommended to separate Vitekta and antacid administration by at
4-urni razmak med dajanjem zdravila Vitekta in antacida.
recommended when
Sočasna
recommended when co-
Pri sočasni uporabi zdravila
recommended when efavirenz
manjšo učinkovitost antimalarikov.
recommended when nelfinavir is
potrebna, ko se nelfinavir jemlje
recommended when these
Med uporabo teh zdravil z
recommended, and the dose of
koagulacijskih testov in
recommended-(↑
(0,71-0,94)
recommended.
elektrokardiograma.
recommended.
fosamprenavirja/ritonavirja ni
recommended.
in manjši odmerki
recommended.
jemanje ne priporoča.
recommended.
lopinavirjem/ritonavirjem je
recommended.
odmerkov.
recommended.
potrebna previdnost.
recommended.
pravastatin
recommended.
priporočamo.
recommended.
priporočljiva, razen če možna
recommended.
priporočljiva.
recommended.
Priporočljivo je
recommended.
Sočasna uporaba ni priporočljiva.
recommended.
Zdravila po terapevtskih področjih
Reconcile 8 mg chewable tablets for dogs Reconcile 16mg chewable tablets for dogs Reconcile 32 mg chewable tablets for dogs Reconcile 64 mg chewable tablets for dogs
Reconcile 8 mg žvečljive tablete za pse Reconcile 16 mg žvečljive tablete za pse Reconcile 32 mg žvečljive tablete za pse Reconcile 64 mg žvečljive tablete za pse
Reconcile 8 mg: fluoxetine 8.0 mg (equivalent to 9.04 mg fluoxetine hydrochloride) Reconcile 16mg: fluoxetine 16.0mg (equivalent to 18.08mg fluoxetine hydrochloride) Reconcile 32 mg: fluoxetine 32.0 mg (equivalent to 36.16 mg fluoxetine hydrochloride) Reconcile 64 mg: fluoxetine 64.0 mg (equivalent to 72.34 mg fluoxetine hydrochloride)
Reconcile 8 mg: fluoksetin 8,0 mg (ustreza 9,04 mg fluoksetin hidroklorida) Reconcile 16 mg: fluoksetin 16,0 mg (ustreza 18,08 mg fluoksetin hidroklorida) Reconcile 32 mg: fluoksetin 32,0 mg (ustreza 36,16 mg fluoksetin hidroklorida) Reconcile 64 mg: fluoksetin 64,0 mg (ustreza 72,34 mg fluoksetin hidroklorida)
Reconcile 8 mg: Fluoxetine 8.0 mg (equivalent to 9.04 mg fluoxetine hydrochloride) Reconcile 16mg: Fluoxetine 16.0mg (equivalent to 18.08mg fluoxetine hydrochloride) Reconcile 32 mg: Fluoxetine 32.0 mg (equivalent to 36.16 mg fluoxetine hydrochloride) Reconcile 64 mg:Fluoxetine 64.0 mg (equivalent to 72.34 mg fluoxetine hydrochloride)
Reconcile 8 mg: fluoksetin 8,0 mg (ustreza 9,04 mg fluoksetin hidroklorida) Reconcile 16 mg: fluoksetin 16,0 mg (ustreza 18,08 mg fluoksetin hidroklorida) Reconcile 32 mg: fluoksetin 32,0 mg (ustreza 36,16 mg fluoksetin hidroklorida) Reconcile 64 mg: fluoksetin 64,0 mg (ustreza 72,34 mg fluoksetin hidroklorida)
Reconcile are flavoured and most dogs will consume the tablet when offered by the owner.
Zdravilo Reconcile ima dodan okus in večina psov bo z veseljem pojedla tableto, ki mu jo bo dal lastnik.
Reconcile has been authorised since 8 July 2008 as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination) and only in combination with behavioural modification techniques.
Reconcile ima dovoljenje za promet od 8. julija 2008, pridobil pa ga je kot pripomoček pri zdravljenju motenj, povezanih z ločitvijo, ki se pri psih kažejo v uničevanju in nesprejemljivem vedenju (lajanju in neustrezni defekaciji oziroma uriniranju) ter samo v kombinaciji s tehnikami za spremembo vedenja.
Reconcile is a speckled tan to brown round chewable tablet containing:
Reconcile so pegaste, svetlo do temno rjave žvečljive tablete, ki vsebujejo:
Reconcile should not be given concomitantly with veterinary medicinal products that lower the seizure threshold (e.g. phenothiazines such as acepromazine or chlorpromazine).
Zdravila Reconcile ni priporočljivo dajati sočasno z veterinarskimi zdravili, ki zmanjšujejo prag napadov krčev (npr. fenotiazini, kot sta acepromazin in klorpromazin).
Reconcile tablets are used as an aid in the treatment of separation-related disorders in dogs, such as destruction and vocalisation and inappropriate defaecation and/or urination.
Tablete Reconcile se uporabljajo kot pripomoček pri zdravljenju motenj, povezanih z ločitvijo, ki se pri psih kaže v uničevanju in nesprejemljivem vedenju ter lajanju in neustrezni defekaciji oziroma uriniranju.
Reconcile tablets may be given with or without food and are flavoured so that most dogs will consume the tablet when offered by the owner.
Tablete Reconcile se lahko dajejo s hrano ali brez nje ter so prijetnega okusa in bo večina psov z veseljem pojedla tableto, ki mu jo bo dal lastnik.
Reconcile tablets should be administered orally with or without food.
Tablete Reconcile se dajejo peroralno s hrano ali brez nje.
Reconcile tablets should not be used in dogs with epilepsy or a history of seizures
Tablet zdravila Reconcile se ne sme uporabljati pri psih z epilepsijo ali anamnezo napadov krčev.
Reconfirm the cord to be injected.
Prepričajte se, če je to pravi vozlič, ki ga je treba zdraviti.
Reconsituted/diluted solution: Use immediately.
Rekonstituirana/razredčena raztopina: Uporabite takoj.
Reconst. ⏐ ⏐ ⏐ ⏐
Priprava:    
Reconstitute 100 mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
100 mg viale rekonstituirajte s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, da dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 100 mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9%) solution for injection, without preservative.
100 mg viale pripravite s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa.
Reconstitute 100-mg vials with 4.2 mL of sodium chloride 9 mg/mL (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/mL pemetrexed.
100 mg viale pripravite s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 100-mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
100 mg viale rekonstituirajte s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 100-mg vials with 4.2 ml of sodium chloride 9 mg/ml (0.9%) solution for injection (without preservative), resulting in a solution containing 25 mg/ml pemetrexed.
100 mg viale pripravite s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 1000-mg vials with 40 ml of sodium chloride 9 mg/ml (0.9%) solution for injection (without preservative), resulting in a solution containing 25 mg/ml pemetrexed.
1000 mg viale pripravite s 40 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 1000-mg vials with 40 ml of sodium chloride 9 mg/ml (0.9%) solution for injection (without preservative), resulting in a solution containing 25 mg/ml pemetrexed.
1000 mg viale pripravite z 40 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 500 mg vials with 20 mL of sodium chloride 9 mg/mL (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/mL pemetrexed.
500 mg viale pripravite z 20 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 500-mg vials with 20 ml of 5% glucose intravenous infusion resulting in a solution containing 25 mg/ml pemetrexed.
Rekonstituirajte 500 mg viale z 20 ml 50 mg/ml (5,0 %) raztopino glukoze za intravensko infundiranje, tako da dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 500-mg vials with 20 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
500 mg viale pripravite z 20 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 500-mg vials with 20 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
500 mg viale rekonstituirajte z 20 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute 500-mg vials with 20 ml of sodium chloride 9 mg/ml (0.9%) solution for injection (without preservative), resulting in a solution containing 25 mg/ml pemetrexed.
500 mg viale pripravite z 20 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute a single dose vial of vaccine with 1 ml of Nobivac Myxo-RHD solvent and inject the total contents of the vial.
Rekonstituirajte vialo z enkratnim odmerkom cepiva z 1 ml Nobivac vehikla in injicirajte vso vsebino viale.
Reconstitute all ReFacto AF pre-filled syringes according to instructions shown above in the reconstitution directions (see Reconstitution and Administration).
Vse napolnjene injekcijske brizge zdravila ReFacto AF pripravite za uporabo po zgornjih navodilih za pripravo zdravila za uporabo (glejte naslova »Priprava zdravila za dajanje« in
Reconstitute and dilute before use
Pred uporabo rekonstituirajte in razredčite.
Reconstitute and dilute before use – see leaflet.
Pred uporabo pripravite in razredčite – glejte navodilo.
Reconstitute and dilute before use – see leaflet.
Pred uporabo rekonstituirajte in razredčite - glejte navodilo za uporabo
Reconstitute and dilute before use.
Pred uporabo pripravite in razredčite. za intravensko uporabo
Reconstitute by swirling gently.
Raztopino pripravimo z rahlim vrtenjem viale in brizge.
Reconstitute dibotermin alfa (rhBMP-2) in a non-sterile field:
Rekonstitucija dibotermina alfa (rhBMP-2) v nesterilnem območju:
Reconstitute Dynastat 40 mg with 2 ml sodium chloride 9 mg/ml (0.9%) solution.
Za pripravo raztopine 40 mg zdravila Dynastat uporabite 2 ml raztopine natrijevega klorida 9 mg/ml (0,9 %).
Reconstitute each 100 mg vial with 4.2 ml of 5% glucose intravenous infusion resulting in a solution containing 25 mg/ml pemetrexed.
Rekonstituirajte 100 mg viale s 4,2 ml 50 mg/ml (5,0 %) raztopino glukoze za intravensko infundiranje, tako da dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute each 100 mg vial with 4.2 ml of 9 mg/ml (0.9 %) sodium chloride solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Vsako 100 mg vialo pripravite s 4,2 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, da dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute each 1000 mg vial with 40 ml of 9 mg/ml (0.9 %) sodium chloride solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
1000 mg viale rekonstituirajte s 40 ml 9 mg/ml (0,9 %) raztopine natrijevega klorida za injiciranje brez konzervansa, tako dobite raztopino, ki vsebuje 25 mg/ml pemetrekseda.
Reconstitute immediately after removal from the refrigerator (or other cold storage).
Cepivo pripravite za uporabo takoj, ko ga vzamete iz hladilnika (ali drugega hlajenega prostora).
Reconstitute immediately before use with solvent provided.
Tik pred uporabo pripravite s priloženim vehiklom.
Reconstitute lyophilised CEPROTIN powder for solution for injection, with the supplied solvent (Sterilised Water for Injections) using the sterile transfer needle.
Liofilizirano zdravilo CEPROTIN prašek za raztopino za injiciranje rekonstituirajte s priloženim vehiklom (sterilna voda za injekcije) z uporabo sterilne pretočne igle.
Reconstitute one dose of lyophilisate with one dose of solvent, shake gently and administer immediately.
En odmerek liofilizata rekonstituirajte z enim odmerkom vehikla, rahlo pretresite in takoj aplicirajte.
Reconstitute one dose of lyophilisate with one dose of solvent, shake gently and administer immediately.
En odmerek praška rekonstituirajte z enim odmerkom vehikla rahlo pretresite in takoj aplicirajte.
Reconstitute one vial of the white lyophilisate using 0.5 ml of the solvent.
Rekonstituirajte eno vialo belega liofilizata z 0,5 ml vehikla.
Reconstitute the content of Ilaris vial at room temperature (typically 15°C to 25°C) by slowly injecting 1.0 ml of water for injections withdrawn from the solvent vial.
Vsebino viale z zdravilom Ilaris rekonstituirajte pri sobni temperaturi (običajno pri 15°C do 25°C), in sicer tako, da v vialo počasi injicirate 1,0 ml vode za injekcije, ki ste jo izvlekli iz viale z vehiklom.
Reconstitute the contents with water for injections and dilute before use.
Pred uporabo vsebino rekonstituirajte z vodo za injekcije in razredčite.
Reconstitute the desired amount of product, repeating steps 2 – 9, using a new syringe and connect it to the venipuncture set.
Za rekonstitucijo želene količine zdravila ponovite korake od 2 do 9, vzemite novo injekcijsko brizgo in jo privijte na pribor za vensko punkcijo.
Reconstitute the lyophilisate as described in section 6.6. Initial intravenous bolus:
Rekonstituirajte liofilizat, kot je opisano v poglavju 6.6. Začetni intravenski bolus:
Reconstitute the lyophilisate immediately and entirely after opening of the cup.
Ko merico odprete, liofilizat takoj in popolnoma rekonstituirajte.
Reconstitute the lyophilisate using water of good quality (e.g. free from chlorine and/or disinfectants).
Liofilizat rekonstituirajte z vodo dobre kakovosti (npr. brez klora in/ali dezinficiensov).
Reconstitute the powder with the solvent
Prašek zmešajte s topilom
Reconstitute the powder with the solvent
Z uporabo vehikla raztopite prašek
Reconstitute the product as described in section 6.6. The reconstituted preparation should be injected/infused slowly intravenously at a rate comfortable for the patient.
Zdravilo pripravite, kot je opisano v poglavju 6.6. Pripravljeno zdravilo je treba injicirati/infundirati počasi intravensko s hitrostjo, udobno za bolnika.
Reconstitute two vials (each containing 20 mg of lepirudin) with 0.4 ml each using either water for injections or sodium chloride 9 mg/ml (0.9 %) solution.
Uporabite dve viali s po 20 mg lepirudina; vsako od njih rekonstituirajte z 0,4 mL vode za injekcije ali z raztopino natrijevega klorida 9 mg/mL (0,9 %).
Reconstitute two vials (each containing 50 mg of lepirudin) with 1 ml each using either water for injections or sodium chloride 9 mg/ml (0.9 %) solution.
Uporabite dve viali s po 50 mg lepirudina; vsako od njih rekonstituirajte z 1 mL vode za injekcije ali z raztopino natrijevega klorida 9 mg/mL (0,9 %).
Reconstitute vedolizumab with 4.8 ml of sterile water for injection, using a syringe with a 21-25 gauge needle.
Vedolizumab rekonstituirajte s 4,8 ml sterilne vode za injekcije s pomočjo injekcijske brizge in injekcijske igle, velikosti 21-25 G.
Reconstitute Visudyne in 7.0 ml water for injections to produce 7.5 ml of a 2.0 mg/ml solution.
Rekonstituirajte zdravilo Visudyne v 7,0 ml vode za injekcije, tako da nastane 7,5 ml raztopine s koncentracijo 2 mg/ml.
Reconstitute with 94 mL of purified water.
Peroralno suspenzijo pripravite s 94 ml prečiščene vode.
Reconstitute with appropriate volume before use.
Pred uporabo rekonstituirajte z ustreznim volumnom.
Reconstitute with sodium pertechnetate (99mTc) injection
Rekonstituirajte z raztopino natrijevega pertehnetata (99mTc) za injiciranje.
Reconstitute ZYPREXA Powder for Solution for Injection only with water for injections.
ZYPREXA prašek za raztopino za injiciranje pripravljajte samo z vodo za injekcije.
Reconstituted and diluted solution for infusion
Pripravljena in razredčena raztopina za infundiranje
Reconstituted and infusion solutions
Rekonstituirane raztopine in raztopine za infundiranje
Reconstituted and radiolabelled material - 4 hours.
rekonstituiran in radioaktivno označen material – 4 ure
Reconstituted and radiolabelled material - 4 hours.
Rekonstituiran in radioaktivno označen material – 4 ure.
Reconstituted concentrate in vial:
Koncentrat v viali:
Reconstituted Kepivance contains 5 mg/ml of palifermin
Pripravljeno zdravilo Kepivance vsebuje 5 mg/ml palifermina.
Reconstituted medicinal product should be inspected visually for particulate matter and discoloration prior to administration.
Rekonstituirano zdravilo je treba pred aplikacijo s prostim očesom pregledati glede vsebnosti trdnih delcev in obarvanosti.
Reconstituted pixantrone solution is stable for up to 24 hours at room temperature (15C to 25C) in standard infusion bags.
Rekonstituirana raztopina piksantrona ostane stabilna 24 ur, če je shranjena pri sobni temperaturi (od 15 °C do 25 °C) v standardnih vrečkah za infundiranje.
Reconstituted product should be used immediately.
Po rekonstituciji je treba zdravilo takoj uporabiti.
Reconstituted Simulect can be administered as an intravenous bolus injection or as an intravenous infusion over 20–30 minutes.
Pripravljeni Simulect lahko dajemo bodisi kot intravensko injekcijo v bolusu bodisi kot intravensko infuzijo v trajanju 20 do 30 minut.
Reconstituted Simulect is administered as an intravenous infusion over 20 to 30 minutes or as a bolus injection.
Pripravljeni Simulect lahko dajemo v obliki intravenske infuzije, trajajoče 20 do 30 minut ali v obliki bolusne injekcije.
Reconstituted solution
64,2 (57,9-70,2)
Reconstituted solution
Pripravljena raztopina
Reconstituted solution
Pripravljena raztopina:
Reconstituted solution
Rekonstituirana raztopina
Reconstituted solution
Rekonstituirana raztopina:
Reconstituted solution
Rekonstitutirana raztopina
Reconstituted solution (BLINCYTO solution):
Rekonstituirana raztopina (raztopina zdravila BLINCYTO):
Reconstituted solution and infusion solution: Store at 15 – 30°C.
Pripravljena raztopina in raztopina za infundiranje: shranjujte pri temperaturi med 15 C in 30 C.
Reconstituted solution and the diluted solution: store between 15°C and 30°C.
Rekonstituirano raztopino in razredčeno raztopino: shranjujte med 15 C in 30 C.
Reconstituted solution, for patients of body weight (kg):
Pripravljena raztopina, za bolnika telesne mase (kg):
Reconstituted solution: 28 days
Pripravljena raztopina: 28 dni
Reconstituted solution: Chemical and physical in-use stability has been demonstrated for 24 hours at 2-8oC.
Rekonstituirana raztopina: kemična in fizikalna stabilnost ob uporabi je bila dokazana za 24 ur pri temperaturi 2 oC - 8 oC.
Reconstituted solution: Chemical and physical in-use stability has been demonstrated for 24 hours at 2-8C.
Rekonstituirana raztopina: kemična in fizikalna stabilnost ob uporabi je bila dokazana za 24 ur pri temperaturi 2 oC - 8 oC.
Reconstituted solution: Store in a refrigerator (2 – 8oC).
Rekonstituirana raztopina: Shranjujte v hladilniku (2 oC - 8 C).
Reconstituted solution: Store in a refrigerator (2-8C).
Pripravljena raztopina: Shranjujte v hladilniku (2 °C - 8 °C).
Reconstituted solutions of Cubicin range in colour from pale yellow to light brown.
Rekonstituirane raztopine zdravila Cubicin se barvno raztezajo ob bledo rumene do svetlo rjave barve.
Reconstituted solutions should be diluted in sodium chloride 9 mg/mL (0.9 %) solution immediately after preparation.
Pripravljeni koncentrat je treba takoj po pripravi razredčiti z raztopino natrijevega klorida 9 mg/ml (0,9 %).
Reconstituted suspension
Rekonstituirana raztopina
Reconstituted suspension: Chemical and physical stability has been demonstrated for 6 hours up to 25ºC.
Rekonstituirana suspenzija: Ugotovljena je bila kemijska in fizikalna stabilnost 6 ur pri temperaturi do 25 ºC.
Reconstituted suspension: do not store above 30°C.
Pripravljeno suspenzijo: shranjujte pri temperaturi do 30 C.
Reconstituted vaccine should be used immediately.
Po rekonstituciji je treba cepivo takoj uporabiti.
Reconstituted vaccine: pink/red, or yellowish colour with slight opalescence
Rekonstituirano cepivo: rožnato/rdeče ali rumenkaste barve, rahlo opalescentno.
Reconstituted vaccine: pink/red, or yellowish colour with slight opalescence.
Rekonstituirano cepivo: rožnato/rdeče ali rumenkaste barve, rahlo opalescentno
Reconstituted vaccine: pinkish, or yellowish colour with slight opalescence.
Rekonstituirano cepivo: rožnate ali rumenkaste barve, rahlo opalescentno
Reconstituted vaccine: pinkish, or yellowish colour with slight opalescence.
Rekonstituirano cepivo: rožnate ali rumenkaste barve, rahlo opalescentno.
Reconstituted vaccine: whitish to yellowish colour with a slight opalescence.
Rekonstituirano cepivo: rožnato/rdeče ali rumenkaste barve, rahlo opalescentno.
Reconstituted VFEND needs to be diluted with a compatible infusion solution first before it is infused. (Please refer to the end of this leaflet for further information).
Tako pripravljeno zdravilo VFEND je treba pred infundiranjem redčiti z združljivo infuzijsko raztopino (dodatne informacije najdete na koncu tega navodila).
Reconstituted Vidaza should be injected subcutaneously (insert the needle at a 45-90o angle) using a 25-gauge needle into the upper arm, thigh or abdomen.
Rekonstituirano zdravilo Vidaza injicirajte subkutano (iglo vstavite pod kotom 45-90°) z iglo velikosti 25 G v nadlaket, stegno ali trebuh.
Reconstituted Visudyne is an opaque dark green solution.
Rekonstituirano zdraviloVisudyne je neprozorna temnozelena raztopina.
Reconstituted Xiapex can be kept at ambient room temperature (20ºC-25ºC) for up to one hour or refrigerated 2ºC-8˚C for up to 4 hours prior to administration.
Rekonstituirano zdravilo Xiapex lahko shranjujete pri sobni temperaturi (20 ºC-25 ºC) največ eno uro ali v hladilniku pri 2 ºC-8 ˚C največ 4 ure pred aplikacijo.
Reconstituted Xiapex can be kept at ambient room temperature (20ºC-25ºC) for up to one hour or refrigerated at 2ºC-8˚C for up to 4 hours prior to administration.
Rekonstituirano zdravilo Xiapex lahko shranjujete pri sobni temperaturi (20 ºC-25 ºC) največ eno uro ali v hladilniku pri 2 ºC- 8 ˚C največ 4 ure pred aplikacijo.
Reconstituted ZYPADHERA remains stable for up to 24 hours in the vial.
Rekonstituirano zdravilo ZYPADHERA ostane v viali stabilno še do 24 ur.
Reconstituted/diluted solutions:
Rekonstituirane/razredčene raztopine:
Reconstituting and drawing up the solution for injection, step by step
Rekonstitucija in izvlek raztopine za injiciranje po korakih
Reconstituting Omnitrope
Priprava zdravila Omnitrope
Reconstituting the solution, step by step
Rekonstitucija raztopine po korakih